Published in Biomaterials on December 01, 2004
Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci (2008) 2.79
Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A (2010) 2.58
Topography, cell response, and nerve regeneration. Annu Rev Biomed Eng (2010) 1.70
Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev (2010) 1.61
Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir Physiol Neurobiol (2009) 1.22
Neurotrophin releasing single and multiple lumen nerve conduits. J Control Release (2005) 1.17
Hydrogel scaffolds for tissue engineering: Progress and challenges. Glob Cardiol Sci Pract (2013) 1.05
Multiple channel bridges for spinal cord injury: cellular characterization of host response. Tissue Eng Part A (2009) 1.02
Accuracy of motor axon regeneration across autograft, single-lumen, and multichannel poly(lactic-co-glycolic acid) nerve tubes. Neurosurgery (2008) 0.96
Surface modification of polydimethylsiloxane (PDMS) induced proliferation and neural-like cells differentiation of umbilical cord blood-derived mesenchymal stem cells. J Mater Sci Mater Med (2008) 0.89
Electroconductive polymeric nanowire templates facilitates in vitro C17.2 neural stem cell line adhesion, proliferation and differentiation. Acta Biomater (2011) 0.89
Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats. Eur Spine J (2005) 0.86
Nerve growth factor expression by PLG-mediated lipofection. Biomaterials (2005) 0.85
The behavior of neuronal cells on tendon-derived collagen sheets as potential substrates for nerve regeneration. Biomaterials (2014) 0.82
Fabrication and characterization of biomimetic multichanneled crosslinked-urethane-doped polyester tissue engineered nerve guides. J Biomed Mater Res A (2013) 0.81
Hyaluronic acid-based scaffold for central neural tissue engineering. Interface Focus (2012) 0.81
Aligned silk-based 3-D architectures for contact guidance in tissue engineering. Acta Biomater (2011) 0.81
Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration. Tissue Eng Part A (2013) 0.81
An overview of tissue engineering approaches for management of spinal cord injuries. J Neuroeng Rehabil (2007) 0.80
Biomimetic micropatterned multi-channel nerve guides by templated electrospinning. Biotechnol Bioeng (2012) 0.78
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
Cellular and paracellular transplants for spinal cord injury: a review of the literature. Childs Nerv Syst (2010) 0.77
Thromboelastometric and platelet responses to silk biomaterials. Sci Rep (2014) 0.75
Evaluation of methods for pore generation and their influence on physio-chemical properties of a protein based hydrogel. Biotechnol Rep (Amst) (2016) 0.75
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell (2012) 5.15
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med (2009) 4.11
Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov (2011) 2.65
Lesions of the Basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning. Neuron (2003) 2.52
Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury. Nat Neurosci (2009) 2.42
The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol (2003) 2.28
Motor axonal regeneration after partial and complete spinal cord transection. J Neurosci (2012) 2.21
Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci (2004) 2.14
NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci (2002) 2.03
Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury. Nat Neurosci (2010) 2.02
JNK3 perpetuates metabolic stress induced by Aβ peptides. Neuron (2012) 1.80
Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron (2009) 1.76
Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J Neurosci (2006) 1.73
The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron (2005) 1.66
Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res (2004) 1.61
Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol (2010) 1.55
Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci (2003) 1.52
Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol Ther (2007) 1.51
A form of motor cortical plasticity that correlates with recovery of function after brain injury. Proc Natl Acad Sci U S A (2006) 1.50
Hippocampal cell genesis does not correlate with spatial learning ability in aged rats. J Comp Neurol (2003) 1.50
Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci (2008) 1.49
Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol (2007) 1.44
Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials (2005) 1.41
Extensive spinal decussation and bilateral termination of cervical corticospinal projections in rhesus monkeys. J Comp Neurol (2009) 1.39
Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc Natl Acad Sci U S A (2009) 1.39
Netrin-1 is a novel myelin-associated inhibitor to axon growth. J Neurosci (2008) 1.36
Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol (2006) 1.36
Bilateral corticospinal projections arise from each motor cortex in the macaque monkey: a quantitative study. J Comp Neurol (2004) 1.35
Performance of locomotion and foot grasping following a unilateral thoracic corticospinal tract lesion in monkeys (Macaca mulatta). Brain (2005) 1.32
Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J Neurosci (2006) 1.30
Kinematic and EMG determinants in quadrupedal locomotion of a non-human primate (Rhesus). J Neurophysiol (2005) 1.27
Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J Comp Neurol (2003) 1.22
Templated agarose scaffolds support linear axonal regeneration. Tissue Eng (2006) 1.21
IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury. Exp Neurol (2008) 1.19
Memory impairment in aged primates is associated with focal death of cortical neurons and atrophy of subcortical neurons. J Neurosci (2004) 1.17
Age-related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery. Neurobiol Aging (2008) 1.17
Local and remote growth factor effects after primate spinal cord injury. J Neurosci (2010) 1.12
Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J Comp Neurol (2002) 1.11
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys. Mov Disord (2007) 1.10
Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials (2010) 1.07
Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects. Exp Neurol (2011) 1.04
Structural plasticity within highly specific neuronal populations identifies a unique parcellation of motor learning in the adult brain. Proc Natl Acad Sci U S A (2011) 1.02
The basal forebrain cholinergic system is required specifically for behaviorally mediated cortical map plasticity. J Neurosci (2009) 1.01
Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J Neurosci (2013) 1.01
Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J Neurosci (2002) 1.01
Transient growth factor delivery sustains regenerated axons after spinal cord injury. J Neurosci (2007) 1.01
Estrogen receptor-beta colocalizes extensively with parvalbumin-labeled inhibitory neurons in the cortex, amygdala, basal forebrain, and hippocampal formation of intact and ovariectomized adult rats. J Comp Neurol (2002) 0.99
Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull (2002) 0.97
NGF is essential for hippocampal plasticity and learning. J Neurosci (2009) 0.96
Estradiol-induced modulation of estrogen receptor-beta and GABA within the adult neocortex: a potential transsynaptic mechanism for estrogen modulation of BDNF. J Comp Neurol (2006) 0.96
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons. Mol Ther (2005) 0.96
Animal models of neurologic disorders: a nonhuman primate model of spinal cord injury. Neurotherapeutics (2012) 0.95
Olfactory ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after spinal cord injury. J Neurosci (2006) 0.93
Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery. Exp Neurol (2008) 0.92
Time Controlled Protein Release from Layer-by-Layer Assembled Multilayer Functionalized Agarose Hydrogels. Adv Funct Mater (2010) 0.92
Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury. Neurotherapeutics (2011) 0.91
Clinical trials in spinal cord injury. J Neurotrauma (2006) 0.90
Development of a database for translational spinal cord injury research. J Neurotrauma (2014) 0.90
Templated agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord transection. Biomaterials (2012) 0.89
Low-density lipoprotein receptor-related protein 1 (LRP1)-dependent cell signaling promotes axonal regeneration. J Biol Chem (2013) 0.89
Unconstrained three-dimensional reaching in rhesus monkeys. Exp Brain Res (2010) 0.89
Transient demyelination increases the efficiency of retrograde AAV transduction. Mol Ther (2010) 0.88
Frontiers of spinal cord and spine repair: experimental approaches for repair of spinal cord injury. Adv Exp Med Biol (2012) 0.87
Spontaneous and neurotrophin-induced axonal plasticity after spinal cord injury. Prog Brain Res (2002) 0.86
Methods for functional assessment after C7 spinal cord hemisection in the rhesus monkey. Neurorehabil Neural Repair (2012) 0.86
A novel inducible tyrosine kinase receptor to regulate signal transduction and neurite outgrowth. J Neurosci Res (2009) 0.83
Gene therapy, neurotrophic factors and spinal cord regeneration. Handb Clin Neurol (2012) 0.80
Association of early experience with neurodegeneration in aged primates. Neurobiol Aging (2009) 0.77
SnoN facilitates axonal regeneration after spinal cord injury. PLoS One (2013) 0.77
Gene therapy and cell transplantation for Alzheimer's disease and spinal cord injury. Yonsei Med J (2004) 0.77
Rebuilding the brain: resurgence of fetal grafting. Nat Neurosci (2007) 0.76
Guest editorial: Opportunities in rehabilitation research. J Rehabil Res Dev (2013) 0.75
The ageless question--what accounts for age-related cognitive decline? Sci Aging Knowledge Environ (2004) 0.75
Therapeutic potential of nervous system growth factors for neurodegenerative disease. Expert Rev Neurother (2002) 0.75
Nucleus hears axon's pain. Nat Med (2004) 0.75